DNTH
Dianthus Therapeutics, Inc. · Healthcare · Biotechnology
Données momentum (gérants comparables) :
étendue des détenteurs +14.3% ·
flux d'actions +30.0% ·
nouvelles positions nettes +12.5%
— formule
Accumulation large — hausse des parts chez un plus grand nombre de détenteurs
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q3 2025
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +12 | 36.60M | $3.56B | +16 | −4 |
| Q1 2026 | 87 | +18 | 31.37M | $2.59B | +21 | −3 |
| Q4 2025 | 69 | +2 | 26.03M | $1.07B | +3 | −1 |
| Q3 2025 | 16 | +2 | 17.27M | $679.58M | +2 | — |
| Q2 2025 | 11 | +1 | 11.18M | $208.23M | +1 | — |
| Q1 2025 | 7 | -2 | 3.50M | $63.53M | — | −2 |
| Q4 2024 | 9 | -1 | 2.27M | $49.52M | +1 | −2 |
| Q3 2024 | 9 | +3 | 1.20M | $32.83M | +4 | −1 |
| Q2 2024 | 6 | — | 1.13M | $29.26M | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 5.97M | +31.4% | $234.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 5.97M | +31.4% | $234.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 5.97M | +31.4% | $234.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 2.04M | +46.6% | $80.35M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passif) | 1.64M | +13.6% | $64.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passif) | 1.64M | +13.6% | $64.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passif) | 1.64M | +13.6% | $64.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.01M | +52.4% | $39.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 1.01M | +52.4% | $39.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passif) | 671.05K | -18.2% | $26.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Marshall Wace ✦ | 572.94K | Nouveau | $22.55M | 0.0% | New | 1 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passif) | 536.41K | +10.6% | $21.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passif) | 536.41K | +10.6% | $21.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 218.77K | — | $8.61M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 218.77K | — | $8.61M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 216.13K | +1921.5% | $8.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 216.13K | +1921.5% | $8.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 146.17K | -25.2% | $5.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Adage Capital Partners ✦ | 77.00K | -58.4% | $3.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | D. E. Shaw & Co. ✦ | 31.61K | Nouveau | $1.24M | 0.0% | New | 1 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Marshall Wace | $22.55M | 0.0% |
| D. E. Shaw & Co. | $1.24M | 0.0% |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 240 détenteurs, 62.10M actions, $4.94B déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.
Achats sur le marché libre (P)
Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.
Ventes sur le marché libre (S)
Director · 2.78K act. · $326,554
Director · 737 act. · $79,721
Director · 831 act. · $90,537
Director · 272 act. · $29,909
Director · 470 act. · $52,194
Director · 397 act. · $44,373
Director · 700 act. · $77,987
Director · 70 act. · $7,498
Director · 2.80K act. · $303,464
Director · 1.80K act. · $196,740
Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie